Contract Pharma

Breaking News | Collaborations & Alliances | Drug Development

Arecor, Lilly Sign Formulation Study Partnership

Arecor will use its proprietary formulation technology platform to develop a differentiated, thermostable formulation of one of Lilly’s proprietary products.

Charles Sternberg, Assistant Editor 05.20.21

The Many Benefits of Outsourcing Stability: A Baxter-Syngene Case study

Learn why Baxter chose to partner with Syngene for Stability studies, the business flow, governance mechanism and metrics that were implemented.

A Systematic Approach to Study Start-Up: Improving Site Activation

...

01.06.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19

The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.

Contract Pharma Staff 12.04.20

Trials & Filings

Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study

Meets all primary efficacy endpoints, demonstrates BNT162b2 to be 95% effective against COVID-19.

Contract Pharma Staff 11.18.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

Moderna Completes Enrollment in Phase III COVID-19 Vax Study

COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.

Contract Pharma Staff 10.22.20

Speed To Study

...

Breaking News | Clinical Trials | CRO News | Drug Development

LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution

Offers integrated data collection, actionable views of critical study data, COVID-19 targeted risk management and recovery assessment.

Contract Pharma Staff 06.29.20

Breaking News | Industry News

Novartis Halts COVID-19 HCQ Study

Discontinues hydroxychloroquine clinical trial based on slow enrollment, no safety issues have been reported or efficacy conclusions made.

Contract Pharma Staff 06.22.20

Clinical Trials | Drug Development | Trials & Filings

Octapharma Extends Funding for COVID-19 Study

Study evaluating using IVIG as investigational coronavirus treatment for adults experiencing respiratory failure.

Contract Pharma Staff 06.03.20

Breaking News | Clinical Trials | Industry News

Tufts CSDD Releases New Study

Establishes demographic benchmarks for pivotal clinical trials, showing areas of under-representation

Contract Pharma Staff 05.12.20

Catalent Provides Clinical Support for COVID-19 Study

Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patients

Contract Pharma Staff 05.08.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Trials & Filings

Humanigen Initiates Phase III Lenzilumab Study in COVID-19

Catalent provides clinical supply support to Humanigen and its partners from its Philadelphia facility

Contract Pharma Staff 05.07.20

Breaking News | Drug Development | Trials & Filings

CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19

Will compare pacritinib plus standard of care versus placebo plus standard of care in 358 patients with severe COVID-19.

Contract Pharma Staff 04.27.20

Clinical Trials | CRO News | Drug Development | Information Technology | R&D

CRO Industry Update

Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.

Online Exclusives Kristin Brooks, Contract Pharma 04.27.20

Breaking News | Drug Development | Industry News

Santhera, CSHL to Investigate Lonodelestat in COVID-19-related ARDS

Lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), has potential as a therapeutic intervention for COVID-19-related ARDS.

Contract Pharma Staff 04.27.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings

Theravance Initiates Study in ALI caused by COVID-19

TD-0903 has potential to inhibit cytokine storm associated with ALI and prevent progression to Acute Respiratory Distress Syndrome

04.23.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

Novartis’ Kymriah Gets RMAT Designation

Investigational new indication to treat patients with relapsed or refractory follicular lymphoma

Contract Pharma Staff 04.22.20

Breaking News | Clinical Trials | CRO News | GMPs/GCPs

Advarra Acquires IRB Company, Inc.

Expands presence of integrated IRB services in North America.

Contract Pharma Staff 04.20.20

Breaking News | Trials & Filings

4D Pharma Begins Phase II COVID-19 Study

MRx-4DP0004, an immunomodulatory therapy, has shown potential to down-regulate hyper-inflammatory response while maintaining anti-viral response

Contract Pharma Staff 04.20.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Moderna Gets $483M BARDA Deal for COVID-19 Vaccine

Award will fund manufacturing process scale-up to enable large-scale production in 2020 for pandemic response

Contract Pharma Staff 04.17.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News

AzurRx, Delpharm Enter Manufacturing Agreement

For the clinical drug product supply of MS1819 therapy for exocrine pancreatic insufficiency

Contract Pharma Staff 04.17.20

Breaking News | Industry News

Eagle Pharma’s Drug Shows Antiviral Activity Against COVID-19

IND submitted to FDA for clinical study at Hackensack University Medical Center to evaluate Ryanodex for treatment of COVID-19 patients

Contract Pharma Staff 04.17.20

Breaking News | Clinical Trials | Industry News

Octapharma Supports New COVID-19 Trial

Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failure

Contract Pharma Staff 04.16.20

Breaking News | Clinical Trials | CRO News | Drug Development

PPD’s AES Biz Launches Patient-Transfer Program

Supports clinical trial continuity for biopharma companies during COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites

Contract Pharma Staff 04.16.20

Clinical Trials | Drug Development

How to Design Trials to be More Patient-Centered

Three lessons learned and how pharma can use validated measures and strategies to engage patients at every stage in the drug development lifecycle.

Jean Paty, Vice President, Patient Centered Sciences, IQVIA, Matthew Reaney, Senior Principal, Patient Centered Sciences, IQVIA 04.16.20

Breaking News | Drug Development | Industry News

Orgenesis to Acquire Tamir Bio Assets

Aims to combine ranpirnase antiviral platform with Bioxome technology for enhanced payload delivery directly to cells.

04.14.20

Breaking News | Clinical Trials | Drug Development | Industry News

Lilly, NIAID to Study Baricitinib in COVID-19

Baricitinib's anti-inflammatory activity has been hypothesized to have a potential benefit in COVID-19

Contract Pharma Staff 04.13.20

Drug Development | R&D

COVID-19 and the Importance of Combating Antimicrobial Resistance

Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial Resistance

Online Exclusives Kristin Brooks, Contract Pharma 04.13.20

Breaking News | Industry News

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening

Contract Pharma Staff 04.13.20

Breaking News | Collaborations & Alliances | Industry News

LabCorp, Ciox Health Partner to Create COVID-19 Patient Data Registry

Groundbreaking registry aims to help researchers accelerate COVID-19 diagnosis, treatment and prevention strategies

Contract Pharma Staff 04.13.20

Bio News | Breaking News | Industry News

Theravance Responds to COVID-19 Pandemic

Advances TD-0903 to treat hospitalized patients with acute lung injury

Contract Pharma Staff 04.13.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Emergent Signs $14.5M COVID-19 BARDA Deal

Partners with U.S. government for comprehensive response to expedite development of plasma-derived therapy for COVID-19

Contract Pharma Staff 04.09.20

Breaking News | Drug Development | Industry News

Roche Accelerates Phase III Actemra Trial in COVID-19

Receives $25 million in support from BARDA to evaluate safety and efficacy in severe COVID-19 pneumonia

Contract Pharma Staff 04.08.20

Clinical Trials | Drug Development | Industry News

Recipharm’s Erdosteine to be Tested for COVID-19 Treatment

Trial in Italy evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2.

Contract Pharma Staff 04.08.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

Hope Bio Gets FDA Nod to Start First Stem Cell COVID-19 Clinical Trial

Autologous mesenchymal stem cells to provide immune support against COVID-19

Contract Pharma Staff 04.07.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

OncoSec Collaborates with Providence Cancer Institute

To conduct first-in-human trial of OncoSec's CORVax12, an investigational vaccine to prevent COVID-19

Contract Pharma Staff 04.07.20

Clinical Trials | Information Technology | QA/QC

Managing Clinical Trials Amid the Coronavirus Pandemic

Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.

Online Exclusives Kristin Brooks, Contract Pharma 04.06.20

Clinical Trials

COVID-19: Keeping Clinical Trials Moving

How DTP and virtual services keep clinical trials moving during pandemic and beyond

Ariette van Strien, President, Marken 04.06.20

Breaking News | Drug Development | Industry News

Izana Initiates Namilumab Study in Worsening COVID-19

Compassionate use study of monoclonal antibody therapy will be evaluated in rapidly worsening COVID-19 patients in Italy

Contract Pharma Staff 04.06.20

Breaking News | Clinical Trials | Industry News

Duke to Expedite Study of COVID-19 Prevention in Healthcare Workers

The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus

Contract Pharma Staff 04.03.20

Breaking News | CRO News | Industry News